Logo
Photo
  • Photo
  • Photo
  • QR Code

Module 8- Treatment Plan Recommendations: Cancer-Related Indications 

This product was sold 1 times.

This eighth module of the Santé Cannabis Prescriber Training Program details treatment plan recommendations for cancer-related indications – cachexia, cancer pain and chemotherapy-induced nausea and vomiting – in five sections.

SECTION I

Describes cancer-related conditions and provides realistic therapeutic goals of a cannabinoid-based treatment.

SECTION II

Presents medical guidelines for Quebec prescribers, summarizes pharmaceutical and non-pharmaceutical conventional treatments for cancer cachexia, cancer pain, and chemotherapy-induced nausea and vomiting.

SECTION III

Gives a general overview of the scientific evidence supporting the use of cannabinoid-based medicines to alleviate cancer cachexia, cancer pain, and chemotherapy-induced nausea and vomiting.

SECTION IV

Provides cannabinoid-based treatment recommendations concerning pharmaceutical cannabinoids, medical cannabis, administration route, cannabinoid selection and special considerations to keep in mind.

SECTION V

Presents three case studies and summarizes learnings from this and prior modules.

SKU Code

MO-0010

Sale Price

39.00 $CAD

Add to Cart
Download the information sheet

Linked Categories

Back to top of the Page
Gestion des fichiers témoins - Manage Cookie Consent
Pour offrir les meilleures expériences, nous utilisons des technologies telles que les cookies pour stocker et/ou accéder aux informations sur l'appareil. Le consentement à ces technologies nous permettra de traiter des données telles que le comportement de navigation ou des identifiants uniques sur ce site. Le fait de ne pas consentir ou de retirer son consentement peut affecter négativement certaines caractéristiques et fonctions.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.